In wake of report on manufacturing difficulties, the Maryland-based drug firm vowed to file for emergency-use authorization by the end of the year.Read More

In wake of report on manufacturing difficulties, the Maryland-based drug firm vowed to file for emergency-use authorization by the end of the year.Read More